Sort
78,016 grants matching “breast cancer”
Effects of Public Information in Cancer (EPIC Center)
$2,000,000University Of Pennsylvania · P50 · FY2003 · CA
COMBINING IMMUNOTHERAPY AND MYC SYNTHETIC LETHALITY FOR METASTATIC BREAST CANCER
$2,000,000Helsingin Yliopisto · · FY2021 · Defense Health Agency
3T MRI Scanner for multidisciplinary imaging and image-guided therapy
$2,000,000Gregory S Karczmar · University Of Chicago · S10 · FY2014 · OD
Alliance for Clinical Trials in Oncology Operations Center
$2,000,000Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2018 · CA
DCTD Screening Technologies
$2,000,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
CENTER FOR SINGLE PHOTON-EMITTING CANCER IMAGING AGENTS
$1,999,999University Of Missouri-Columbia · P50 · FY2003 · CA
Core-001
$1,999,999Mary Beth Terry · Columbia University Health Sciences · U01 · FY2021 · CA
IGF::OT::IGF SYSTEMIC RADIONUCLIDE THERAPY TARGETED TO VEGF RECEPTORS IN TUMOR VASCULATURE
$1,999,999Joseph Backer · Sibtech, Inc. · N43 · FY2017 · CA
Breast Cancer Family Registry Cohort
$1,999,999Mary Beth Terry · Columbia University Health Sciences · U01 · FY2021 · CA
Comparative effectiveness in genomic & personalized medicine for colon cancer
$1,999,998Katrina A Goddard · Kaiser Foundation Research Institute · RC2 · FY2009 · CA
6 MeV/amu ion linac for deep-penetration microbeam and millimeter-beam charged-particle irradiations in small animals and biological tissues
$1,999,985David Jonathan Brenner · Columbia University Health Sciences · S10 · FY2018 · OD
Michigan Center for Health Communications Research
$1,999,982University Of Michigan At Ann Arbor · P50 · FY2004 · CA
Michigan Center for Health Communications Research
$1,999,968University Of Michigan At Ann Arbor · P50 · FY2005 · CA
Topic 353: Highly Accurate Low Cost ctDNA Diagnostics with Magnetic Nanoparticle Enabled Automated Sample Prep - Moonshot
$1,999,962Aihua Fu · Nvigen, Inc. · N44 · FY2019 · CA
Combating Subclonal Evolution of Resistant Cancer Phenotypes
$1,999,948Andrea Hope Bild · Beckman Research Institute/City Of Hope · U54 · FY2019 · CA
Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care
$1,999,936Jane C. Weeks · Dana-Farber Cancer Inst · RC2 · FY2009 · CA
Comparative effectiveness of breast imaging strategies in community practice
$1,999,896Diana L Miglioretti · Kaiser Foundation Health Plan Of Washington · RC2 · FY2009 · CA
Centers of Excellence in Cancer Communications Research
$1,999,793Saint Louis University · P50 · FY2003 · CA
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
$1,999,788Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
IGF::OT::IGF I-125-CLR1404 AS A (NEO) ADJUVANT TREATMENT OPTION FOR TRIPLE-NEGATIVE BREAST CANCER
$1,999,370Benjamin Titz · Cellectar Biosciences, Inc. · N43 · FY2016 · CA
Programs in Clinical Effectiveness of Cancer Pharmacogenomics
$1,999,347Geoffrey S Ginsburg · Duke University · UC2 · FY2010 · CA
Comparative Effectiveness of Advanced Imaging in Cancer
$1,999,273Anna N. A. Tosteson · Dartmouth College · RC2 · FY2009 · CA
Targeted 2nd generation sequencing in phenotyped Framingham & PGP populations.
$1,998,275George M Church · Harvard Medical School · R01 · FY2008 · HL
MARKERS OF BREAST CANCER EVOLUTION AND PROGRESSION
$1,998,272Baylor College Of Medicine · P01 · FY2001 · CA
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
$1,998,201Laura J Esserman · University Of California, San Francisco · R01 · FY2021 · CA